In vitro multi-organ system by Hesperos, Inc. realistically replicates the responses of cancer treatments and has potential to inform treatment decisions. ORLANDO, FLA – June 19, 2019 — A reconfigurable “body-on-a-chip” model could transform drug development … Read More
The interest in our human-on-a-chip model continues to grow. Last week we brought our systems to the National Center for Translational Science (NCATS) at the NIH in Washington, D.C. to perform a real-time demo using live … Read More
Collaboration between L’Oreal, Hesperos and UCF results in further reduction in reliance on animal testing in drug and cosmetics development (ORLANDO, Fla.) The replacement of animals as test subjects is one step closer to reality with … Read More
We’ve been forging new frontiers with our human-on-a-chip multi-organ models—could the next one take us into space? Last month, we traveled to Washington, DC, to attend a workshop with officials from NASA,NCATS (National Center for Advancing … Read More
We were proud to join hundreds of Florida’s executives, scientists, researchers, investors, legislators, and service providers from the biopharmaceutical, medical device, and healthIT at the recent BioFlorida Annual Conference to celebrate Florida innovation and achievements — … Read More
(ORLANDO, Fla.) Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more … Read More
ORLANDO, FLA – September 6, 2018 — Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center … Read More